Item 1. Financial Statements
Item 1. Financial Statements.
Axcelis Technologies, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
Revenue:
Product
$
265,673
$
213,926
$
511,680
$
410,458
Services
8,297
7,251
16,310
14,314
Total revenue
273,970
221,177
527,990
424,772
Cost of revenue:
Product
146,741
115,754
289,512
223,395
Services
7,526
6,242
14,756
12,429
Total cost of revenue
154,267
121,996
304,268
235,824
Gross profit
119,703
99,181
223,722
188,948
Operating expenses:
Research and development
24,130
18,731
47,903
35,704
Sales and marketing
15,537
12,703
29,681
23,994
General and administrative
16,328
13,602
31,073
26,180
Total operating expenses
55,995
45,036
108,657
85,878
Income from operations
63,708
54,145
115,065
103,070
Other income (expense):
Interest income
4,307
352
8,243
447
Interest expense
( 1,349 )
( 1,250 )
( 2,702 )
( 2,768 )
Other, net
( 2,050 )
( 5,051 )
( 3,088 )
( 6,669 )
Total other income (expense)
908
( 5,949 )
2,453
( 8,990 )
Income before income taxes
64,616
48,196
117,518
94,080
Income tax provision
3,037
4,007
8,242
8,276
Net income
$
61,579
$
44,189
$
109,276
$
85,804
Net income per share:
Basic
$
1.88
$
1.34
$
3.34
$
2.59
Diluted
$
1.86
$
1.32
$
3.29
$
2.54
Shares used in computing net income per share:
Basic weighted average shares of common stock
32,775
33,096
32,759
33,170
Diluted weighted average shares of common stock
33,189
33,562
33,237
33,770
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
3
Table of Contents
Axcelis Technologies, Inc.
Consolidated Statements of Comprehensive Income
(In thousands)
(Unaudited)
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
Net income
$
61,579
$
44,189
$
109,276
$
85,804
Other comprehensive loss:
Foreign currency translation adjustments
( 1,011 )
( 2,685 )
( 961 )
( 3,871 )
Amortization of actuarial net gain and other adjustments from pension plan, net of tax
—
8
—
17
Total other comprehensive loss
( 1,011 )
( 2,677 )
( 961 )
( 3,854 )
Comprehensive income
$
60,568
$
41,512
$
108,315
$
81,950
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
4
Table of Contents
Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)
June 30,
December 31,
2023
2022
ASSETS
Current assets:
Cash and cash equivalents
$
132,504
$
185,595
Short-term investments
320,360
246,571
Accounts receivable, net
159,199
169,773
Inventories, net
299,841
242,406
Prepaid expenses and other current assets
38,265
33,300
Total current assets
950,169
877,645
Property, plant and equipment, net
43,156
39,664
Operating lease assets
31,998
12,146
Finance lease assets, net
17,305
17,942
Long-term restricted cash
6,652
752
Deferred income taxes
38,944
31,701
Other assets
33,494
33,791
Total assets
$
1,121,718
$
1,013,641
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
60,504
$
62,346
Accrued compensation
17,216
35,540
Warranty
10,867
8,299
Income taxes
6,598
4,304
Deferred revenue
138,890
123,471
Current portion of finance lease obligation
1,367
1,229
Other current liabilities
13,018
12,943
Total current liabilities
248,460
248,132
Long-term finance lease obligation
44,455
45,185
Long-term deferred revenue
43,650
31,306
Other long-term liabilities
41,116
21,762
Total liabilities
377,681
346,385
Commitments and contingencies (Note 16)
Stockholders’ equity:
Common stock, $ 0.001 par value, 75,000 shares authorized; 32,836 shares issued and outstanding at June 30, 2023; 32,775 shares issued and outstanding at December 31, 2022
33
33
Additional paid-in capital
540,120
550,299
Retained earnings
206,813
118,892
Accumulated other comprehensive loss
( 2,929 )
( 1,968 )
Total stockholders’ equity
744,037
667,256
Total liabilities and stockholders’ equity
$
1,121,718
$
1,013,641
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
5
Table of Contents
Axcelis Technologies, Inc.
Consolidated Statements of Stockholders’ Equity
(In thousands)
(Unaudited)
(Accumulated
Accumulated
Additional
Deficit)
Other
Total
Common Stock
Paid-in
Retained
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Income
Equity
Balance at December 31, 2021
33,240
$
33
$
559,883
$
( 22,722 )
$
1,765
$
538,959
Net income
—
—
—
41,614
—
41,614
Foreign currency translation adjustments
—
—
—
—
( 1,186 )
( 1,186 )
Change in pension obligation
—
—
—
—
9
9
Exercise of stock options
41
—
491
—
—
491
Issuance of common stock on restricted stock units, net of shares withheld
67
—
( 3,315 )
—
—
( 3,315 )
Stock-based compensation expense
—
—
2,701
—
—
2,701
Repurchase of common stock
( 284 )
—
( 5,127 )
( 14,873 )
—
( 20,000 )
Balance at March 31, 2022
33,064
$
33
$
554,633
$
4,019
$
588
$
559,273
Net income
—
—
—
44,189
—
44,189
Foreign currency translation adjustments
—
—
—
—
( 2,685 )
( 2,685 )
Change in pension obligation
—
—
—
—
8
8
Exercise of stock options
25
—
298
—
—
298
Issuance of stock under Employee Stock Purchase Plan
15
—
711
—
—
711
Issuance of common stock on restricted stock units, net of shares withheld
205
—
( 5,896 )
—
—
( 5,896 )
Stock-based compensation expense
—
—
3,527
—
—
3,527
Repurchase of common stock
( 215 )
—
( 3,872 )
( 8,626 )
—
( 12,498 )
Balance at June 30, 2022
33,094
$
33
$
549,401
$
39,582
$
( 2,089 )
$
586,927
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Retained
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Loss
Equity
Balance at December 31, 2022
32,775
$
33
$
550,299
$
118,892
$
( 1,968 )
$
667,256
Net income
—
—
—
47,697
—
47,697
Foreign currency translation adjustments
—
—
—
—
50
50
Exercise of stock options
2
—
25
—
25
Issuance of common stock on restricted stock units, net of shares withheld
56
—
( 3,907 )
—
—
( 3,907 )
Stock-based compensation expense
—
—
3,199
—
—
3,199
Repurchase of common stock
( 107 )
—
( 1,924 )
( 10,575 )
—
( 12,499 )
Balance at March 31, 2023
32,726
$
33
$
547,692
$
156,014
$
( 1,918 )
$
701,821
Net income
—
—
—
61,579
—
61,579
Foreign currency translation adjustments
—
—
—
—
( 1,011 )
( 1,011 )
Issuance of stock under Employee Stock Purchase Plan
6
—
957
—
—
957
Issuance of common stock on restricted stock units, net of shares withheld
199
—
( 11,558 )
—
—
( 11,558 )
Stock-based compensation expense
—
—
4,749
—
4,749
Repurchase of common stock
( 95 )
—
( 1,720 )
( 10,780 )
—
( 12,500 )
Balance at June 30, 2023
32,836
$
33
$
540,120
$
206,813
$
( 2,929 )
$
744,037
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
6
Table of Contents
Axcelis Technologies, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Six months ended
June 30,
2023
2022
Cash flows from operating activities
Net income
$
109,276
$
85,804
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
6,258
5,724
Deferred income taxes
( 7,413 )
3,934
Stock-based compensation expense
7,948
6,228
Provision for excess and obsolete inventory
2,494
2,061
Accretion of discounts and premiums on marketable securities
( 5,753 )
—
Currency loss on foreign denominated transactions
5,717
—
Changes in operating assets and liabilities:
Accounts receivable
8,173
( 45,783 )
Inventories
( 63,294 )
( 27,511 )
Prepaid expenses and other current assets
( 5,095 )
( 5,304 )
Accounts payable and other current liabilities
( 18,266 )
1,507
Deferred revenue
28,075
3,290
Income taxes
2,324
( 529 )
Other assets and liabilities
( 3,170 )
( 199 )
Net cash provided by operating activities
67,274
29,222
Cash flows from investing activities
Expenditures for property, plant and equipment and capitalized software
( 5,202 )
( 3,356 )
Purchase of short-term investments
( 188,943 )
—
Maturities of short-term investments
120,907
—
Net cash used in investing activities
( 73,238 )
( 3,356 )
Cash flows from financing activities
Net settlement on restricted stock grants
( 15,465 )
( 9,211 )
Repurchase of common stock
( 24,999 )
( 32,498 )
Proceeds from Employee Stock Purchase Plan purchases
957
711
Principal payments on finance lease obligation
( 598 )
( 475 )
Proceeds from exercise of stock options
25
789
Net cash used in financing activities
( 40,080 )
( 40,684 )
Effect of exchange rate changes on cash and cash equivalents
( 1,147 )
7,058
Net decrease in cash, cash equivalents and restricted cash
( 47,191 )
( 7,760 )
Cash, cash equivalents and restricted cash at beginning of period
186,347
295,680
Cash, cash equivalents and restricted cash at end of period
$
139,156
$
287,920
See accompanying Notes to these Consolidated Financial Statements (Unaudited)
7
Table of Contents
Axcelis Technologies, Inc.
Notes to Consolidated Financial Statements (Unaudited)
Note 1. Nature of Business
Axcelis Technologies, Inc. (“Axcelis” or the “Company”) was incorporated in Delaware in 1995 and is a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, we provide extensive worldwide aftermarket service and support, including spare parts, equipment upgrades, used equipment and maintenance services to the semiconductor industry.
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments which are of a normal recurring nature and considered necessary for a fair presentation of these financial statements have been included. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for other interim periods or for the year as a whole.
The balance sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. As of June 30, 2023, there have been no material changes in the Company’s significant accounting policies. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Note 2. Stock-Based Compensation
We maintain the Axcelis Technologies, Inc. 2012 Equity Incentive Plan, as amended (the “2012 Equity Plan”), an Internal Revenue Code Section 423 plan, which became effective on May 2, 2012, and permits the issuance of options, restricted stock, restricted stock units (“RSUs”) and performance awards to selected employees, directors and consultants of the Company.
The 2012 Equity Plan is more fully described in Note 13 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022.
We recognized stock-based compensation expense of $ 4.7 million and $ 3.5 million for the three-month periods ended June 30, 2023 and 2022, respectively. We recognized stock-based compensation expense of $ 7.9 million and $ 6.2 million for the six-month periods ended June 30, 2023 and 2022, respectively. These amounts include compensation expense related to RSUs, non-qualified stock options and stock to be issued to participants under the 2020 Employee Stock Purchase Plan (the “2020 ESPP”).
In the three-month periods ended June 30, 2023 and 2022, we issued 0.2 million and 0.2 million of common stock for purchases under the 2020 ESPP and vesting of RSUs, respectively. In the three-month period ended June 30, 2023, we received proceeds of $ 1.0 million for purchases under the 2020 ESPP. In the three-month period ended June 30, 2022, we received proceeds of $ 1.0 million in connection with the exercise of stock options and purchases under the 2020 ESPP.
In the six-month periods ended June 30, 2023 and 2022, we issued 0.3 million and 0.4 million shares of common stock, respectively, upon stock option exercises, purchases under the 2020 ESPP and vesting of RSUs. In the six-month periods ended June 30, 2023 and 2022, we received proceeds of $ 1.0 million and $ 1.5 million, respectively, in connection with the exercise of stock options and purchases under the 2020 ESPP.
Note 3. Leases
We have operating leases for manufacturing, office space, warehouse space, computer and office equipment and vehicles used in our business operations. We have a finance lease in relation to the 2015 sale-leaseback of our corporate headquarters in Beverly, Massachusetts. We review all agreements to determine if the agreement contains a lease component. An agreement contains a lease component if it provides for the use of a specific physical space or a specific physical item.
8
Table of Contents
We recognize operating lease obligations under Accounting Standards Codification Topic 842, Leases . The guidance in Topic 842 requires recognition of lease assets and related liabilities on a discounted basis using the explicit or implicit discount rate stated within the agreement. We recognize a corresponding right-of-use asset, which is initially determined based upon the net present value of the associated liability and is adjusted for deferred costs and possible impairment, if any. For those lease agreements that do not indicate the applicable discount rate, we use our incremental borrowing rate. We have made the following policy elections: (i) operating leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet; (ii) we recognize lease expense for operating leases on a straight-line basis over the lease term; and (iii) we account for lease components and non-lease components that are fixed payments as one component. Some of our operating leases include one or more options to renew , with renewal terms that can extend the respective lease term by one to three years . The exercise of lease renewal options is at our sole discretion. For lease extensions that are reasonably certain to occur, we have included the renewal periods in our calculation of the net present value of the lease obligation and related right-of-use asset. Certain leases also include options to purchase the leased property. The depreciable life of certain assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. The amounts of operating and finance lease right-of-use assets and related lease obligations recorded within our consolidated balance sheets are as follows:
June 30,
December 31,
Leases
Classification
2023
2022
Assets
(in thousands)
Operating leases
Operating lease assets
$
31,998
$
12,146
Finance lease
Finance lease assets*
17,305
17,942
Total leased assets
$
49,303
$
30,088
Liabilities
Current
Operating
Other current liabilities
$
5,544
$
5,367
Finance
Current portion of finance lease obligation
1,367
1,229
Non-current
Operating
Other long-term liabilities
25,979
6,931
Finance
Finance lease obligation
44,455
45,185
Total lease liabilities
$
77,345
$
58,712
*Finance lease assets are recorded net of accumulated depreciation of $ 46.5 million and include $ 0.6 million of prepaid financing costs as of June 30, 2023. Finance lease assets are recorded net of accumulated depreciation of $ 45.9 million and include $ 0.6 million of prepaid financing costs as of December 31, 2022.
All of our operating lease office locations support selling and servicing functions. Our Axcelis Asia Operations Center facility in South Korea brings production capability closer to our Asia-based customers. Our state-of-the-art 98,500 square foot logistics and flex manufacturing center in Beverly, Massachusetts, which is anticipated to be fully operational in the second half of 2023, commenced during the three-months ended June 30, 2023. As a result, we recorded a right-of-use asset of $ 21.0 million, which includes approximately $ 1.0 million of prepaid rent, and a related liability of $ 20.0 million.
9
Table of Contents
Operating lease expense and depreciation and interest expense relating to our finance lease obligation are recognized within our consolidated statement of operations for the three and six months ended June 30, 2023 and 2022 as follows:
Three months ended
Six months ended
June 30,
June 30,
Lease cost
Classification
2023
2022
2023
2022
Operating lease cost
(in thousands)
Product / services*
Cost of revenue
$
1,821
$
1,306
$
3,287
$
2,516
Research and development
Operating expenses
137
76
243
132
Sales and marketing*
Operating expenses
417
368
813
787
General and administrative*
Operating expenses
239
308
515
520
Total operating lease cost
$
2,614
$
2,058
$
4,858
$
3,955
Finance lease cost
Depreciation of leased assets
Cost of revenue, R&D, Sales and marketing and G&A
$
318
$
325
$
637
$
648
Interest on lease liabilities
Interest expense
1,223
1,274
2,454
2,532
Total finance lease cost
$
1,541
$
1,599
$
3,091
$
3,180
Total lease cost
$
4,155
$
3,657
$
7,949
$
7,135
* Product / services, sales and marketing and general and administrative expense also includes short-term lease and variable lease costs of approximately $ 0.5 million and $ 1.0 million for the three and six months ended June 30, 2023, respectively, and includes short-term lease and variable lease costs of approximately $ 0.6 million and $ 1.0 million for the three and six months ended June 30, 2022, respectively.
The lease of our corporate headquarters, shown below under finance leases, had an original lease term of 22 years , beginning in January 2015 and expiring in January 2037, with renewal options. All other locations are treated as operating leases, with lease terms ranging from one to sixteen years . The tables below reflect the minimum cash outflow regarding our current lease obligations as well as the weighted-average remaining lease term and weighted-average discount rates used in our calculation of our lease obligations and right-of-use assets as of June 30, 2023:
Finance
Operating
Total
Maturity of Lease Liabilities
Leases
Leases
Leases
(in thousands)
2023
$
3,063
$
4,335
$
7,398
2024
6,252
5,766
12,018
2025
5,930
4,308
10,238
2026
6,008
3,247
9,255
2027
6,128
2,411
8,539
Thereafter
61,586
25,080
86,666
Total lease payments
$
88,967
$
45,147
$
134,114
Less interest portion*
( 43,145 )
( 13,624 )
( 56,769 )
Finance lease and operating lease obligations
$
45,822
$
31,523
$
77,345
* Finance lease interest calculated using the implied interest rate; operating lease interest calculated using estimated corporate borrowing rate.
The table above does not include options to renew lease terms that are not reasonably certain of being exercised.
10
Table of Contents
June 30,
Lease term and discount rate
2023
Weighted-average remaining lease term (years):
Operating leases
11.7
Finance leases
13.6
Weighted-average discount rate:
Operating leases
5.4 %
Finance leases
10.5 %
Our cash outflows from our operating leases include rent expense and other charges associated with these leases. These cash flows are included within the operating activities section of our statement of cash flows. Our cash flows from our finance lease include both an interest component and a principal component. The table below shows our cash outflows by lease type and related section of our statement of cash flows, as well as the non-cash amount capitalized on our balance sheet in relation to our operating lease right-of-use assets for the six months ended June 30, 2023 and 2022, respectively:
Six months ended June 30,
Cash paid for amounts included in the measurement of lease liabilities
2023
2022
(in thousands)
Operating cash outflows from operating leases
$
4,858
$
3,955
Operating cash outflows from finance leases
2,454
2,509
Financing cash outflows from finance leases
598
475
Operating lease assets obtained in exchange for operating lease liabilities
23,289
4,714
Finance lease assets obtained in exchange for new finance lease liabilities
—
—
Note 4. Revenue
To reflect the organization of our business operations, we divide revenue into two categories: revenue from sales of new systems and revenue arising from the sale of used systems, parts and labor to customers who own systems, which we refer to as “Aftermarket.”
Revenue by categories used by management are as follows:
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
(in thousands)
Systems
$
215,174
$
165,350
$
410,372
$
317,152
Aftermarket
58,796
55,827
117,618
107,620
Total Revenue
$
273,970
$
221,177
$
527,990
$
424,772
11
Table of Contents
We also consider revenue by geography. Revenue is allocated to geographic markets based upon the location to which our products are shipped and in which our services are performed. Revenue in our principal geographic markets is as follows:
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
(in thousands)
North America
$
37,918
$
34,683
$
83,084
$
59,596
Asia Pacific
205,941
168,705
397,044
317,945
Europe
30,111
17,789
47,862
47,231
Total Revenue
$
273,970
$
221,177
$
527,990
$
424,772
Our system sales revenue transactions give rise to contract liabilities (in the case of pre-payments and the fair value of goods and services to be delivered after the system delivery, such as installation and certain warranty obligations).
Contract liabilities are as follows:
June 30,
December 31,
2023
2022
(in thousands)
Contract liabilities
$
182,540
$
154,777
Contract liabilities are reflected as deferred revenue on the consolidated balance sheet and relate to payments invoiced or received in advance of completion of performance obligations under a contract. Contract liabilities are recognized as revenue upon the fulfillment of performance obligations.
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
(in thousands)
Balance, beginning of the period
$
201,725
$
74,840
$
154,777
$
68,436
Deferral of revenue
34,977
28,703
107,556
46,697
Recognition of deferred revenue
( 54,162 )
( 31,994 )
( 79,793 )
( 43,584 )
Balance, end of the period
$
182,540
$
71,549
$
182,540
$
71,549
The majority of our system transactions have either (1) payment terms of 90 % due upon shipment of the system and 10 % due upon acceptance or (2) a deposit with the remaining balance due at shipment and acceptance. Aftermarket transaction payment terms typically provide that payment is due either within 30 or 60 days after the service is provided or parts delivered.
Note 5. Receivables and Allowances for Credit Losses
All trade receivables are reported on the consolidated balance sheets at their amortized cost adjusted for any write-offs and net of allowances for credit losses.
We maintain an allowance for credit losses, which represent an estimate of expected losses over the remaining contractual life of our receivables, considering current market conditions and estimates for supportable forecasts when appropriate. The estimate is a result of our ongoing assessments and evaluations of collectability, historical loss experience, and future expectations in estimating credit losses in our receivable portfolio. We use historical loss experience rates and apply them to a related aging analysis while also considering customer and/or economic risk where appropriate. Determination of the proper amount of allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, as a result, net earnings. The allowance takes into consideration numerous quantitative and qualitative factors that include receivable type, historical loss
12
Table of Contents
experience, loss migration, delinquency trends, collection experience, current economic conditions, trade restrictions, estimates for supportable forecasts, when appropriate, and credit risk characteristics.
We evaluate the credit risk of the customer when extending credit based on a combination of financial and qualitative factors that may affect our customers’ ability to pay. These factors may include the customer’s financial condition, past payment experience, and credit bureau report, as well as the value of the underlying collateral.
Management performs detailed reviews of our receivables on a quarterly basis to assess the adequacy of the allowances and to determine if any impairment has occurred. Amounts determined to be uncollectable are charged directly against the allowances, while amounts recovered on previously written-off accounts increase the allowances. Changes to the allowances for credit losses are maintained through adjustments to the provision for credit losses, which are charged to current period earnings. We did not incur any credit losses or recoveries for the three and six-month periods ended June 30, 2023 and 2022, respectively. As of June 30, 2023 and 2022, respectively, we had no provision for credit losses.
Note 6. Computation of Net Earnings per Share
Basic earnings per share is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of shares of common stock outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased by the number of additional shares of common stock that would have been outstanding if the potentially dilutive shares of common stock issuable on exercise of stock options and vesting of RSUs had been issued, calculated using the treasury stock method.
The components of net earnings per share are as follows:
Three months ended
Six months ended
June 30,
June 30,
2023
2022
2023
2022
(in thousands, except per share amounts)
Net income available to common stockholders
$
61,579
$
44,189
$
109,276
$
85,804
Weighted average shares of common stock outstanding used in computing basic income per share
32,775
33,096
32,759
33,170
Incremental options and RSUs
414
466
478
600
Weighted average shares of common stock used in computing diluted net income per share
33,189
33,562
33,237
33,770
Net income per share
Basic
$
1.88
$
1.34
$
3.34
$
2.59
Diluted
$
1.86
$
1.32
$
3.29
$
2.54
Diluted weighted average shares of common stock outstanding does not include 770 and 15,796 common equivalent shares issuable with respect to outstanding equity awards for the three-month periods ended June 30, 2023 and 2022, respectively, or 387 and 8,255 common equivalent shares issuable with respect to outstanding equity awards for the six-month periods ended June 30, 2023 and 2022, respectively, as their effect would have been anti-dilutive.
Note 7. Accumulated Other Comprehensive Loss
The following table presents the changes in accumulated other comprehensive loss, net of tax, by component, for the six months ended June 30, 2023:
Foreign
Defined benefit
currency
pension plan
Total
(in thousands)
Balance at December 31, 2022
$
( 1,994 )
$
26
$
( 1,968 )
Other comprehensive loss and pension reclassification
( 961 )
—
( 961 )
Balance at June 30, 2023
$
( 2,955 )
$
26
$
( 2,929 )
13
Table of Contents
Note 8. Cash, cash equivalents and restricted cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the total of the amounts shown in the statement of cash flows:
June 30,
December 31,
2023
2022
(in thousands)
Cash and cash equivalents
$
132,504
$
185,595
Long-term restricted cash
6,652
752
Total cash, cash equivalents and restricted cash
$
139,156
$
186,347
As of June 30, 2023, we had $ 6.7 million in restricted cash representing the total of (i) a $ 5.9 million cash collateral relating to our lease for our headquarters in Beverly, Massachusetts, (ii) a $ 0.7 million letter of credit relating to workers’ compensation insurance and (iii) a $ 0.1 million deposit relating to customs activity. See Note 12 for further discussion on the $ 5.9 million cash collateral.
Note 9. Inventories, net
The components of inventories are as follows:
June 30,
December 31,
2023
2022
(in thousands)
Raw materials
$
213,535
$
187,313
Work in process
53,693
35,069
Finished goods (completed systems)
32,613
20,024
Inventories, net
$
299,841
$
242,406
When recorded, inventory reserves reduce the carrying value of inventories to their net realizable value. We establish inventory reserves when conditions exist that indicate inventory may be in excess of anticipated demand or is obsolete based upon assumptions about future demand for the Company’s products or market conditions. We regularly evaluate the ability to realize the value of inventories based on a combination of factors including the following: forecasted sales or usage, estimated product end of life dates, estimated current and future market value and new product introductions. Purchasing and usage alternatives are also explored to mitigate inventory exposure.
Note 10. Product Warranty
We generally offer a one-year warranty for all of our systems, the terms and conditions of which vary depending upon the product sold. For all systems sold, we accrue a liability for the estimated cost of standard warranty at the time of system shipment and defer the portion of systems revenue attributable to the fair value of non-standard warranty. Costs for non-standard warranty are expensed as incurred. Factors that affect our warranty liability include the number of installed units, historical and anticipated product failure rates, material usage and service labor costs. We periodically assess the adequacy of our recorded liability and adjust the amount as necessary.
14
Table of Contents
The changes in our standard product warranty liability are as follows:
Six months ended
June 30,
2023
2022
(in thousands)
Balance at January 1 (beginning of year)
$
10,487
$
6,924
Warranties issued during the period
5,616
4,902
Settlements made during the period
( 4,834 )
( 2,819 )
Changes in estimate of liability for pre-existing warranties during the period
1,552
12
Balance at June 30 (end of period)
$
12,821
$
9,019
Amount classified as current
$
10,867
$
8,348
Amount classified as long-term (within other long-term liabilities)
1,954
671
Total warranty liability
$
12,821
$
9,019
Note 11. Fair Value Measurements
Fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
(a) Fair Value Hierarchy
The accounting guidance for fair value measurement requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:
Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
(b) Fair Value Measurements
Our money market funds and short-term investments with initial maturities of three months or less are included in cash and cash equivalents in the consolidated balance sheets. Other investments that have a maturity of greater than three months but less than one year are included within short-term investments in the consolidated balance sheets.
15
Table of Contents
The following table sets forth our assets by level within the fair value hierarchy:
June 30, 2023
Fair Value Measurements
Level 1
Level 2
Level 3
Total
(in thousands)
Assets
Cash equivalents and other short-term investments:
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments)
$
88,903
$
—
$
—
$
88,903
Short-term investments (U.S. Government Securities and Agency Investments)
319,587
—
—
319,587
Total
$
408,490
$
—
$
—
$
408,490
December 31, 2022
Fair Value Measurements
Level 1
Level 2
Level 3
Total
(in thousands)
Assets
Cash equivalents and other short-term investments:
Cash equivalents (money market funds, U.S. Government Securities and Agency Investments)
$
111,771
$
25,000
$
—
$
136,771
Short-term investments (U.S. Government Securities and Agency Investments)
245,247
—
—
245,247
Total
$
357,018
$
25,000
$
—
$
382,018
(c) Other Financial Instruments
The carrying amounts reflected in the consolidated balance sheets for accounts receivable, prepaid expenses and other current assets and non-current assets, restricted cash, accounts payable and accrued expenses approximate fair value due to their short-term maturities.
Note 12. Financing Arrangements
On January 30, 2015, we sold our corporate headquarters facility in Beverly, Massachusetts for $ 48.9 million. As part of the sale, we also entered into a 22-year lease agreement of our headquarters facility. This sale-leaseback is accounted for as a financing lease under generally accepted accounting principles and, as such, we have recorded a financing obligation of $ 45.8 million as of June 30, 2023. The associated lease payments include both an interest component and payment of principal, with the remaining liability being extinguished at the end of the original lease term. As of June 30, 2023, we have a security deposit of $ 5.9 million related to this lease.
On April 5, 2023 we terminated the Senior Secured Credit Facilities Credit Agreement, as amended (the “Credit Agreement”), with Silicon Valley Bank that we entered into on July 31, 2020. The Credit Agreement provided for a revolving credit facility covering borrowings and letters of credit in an aggregate principal amount not to exceed $ 40.0 million. Our obligations under the Credit Agreement were secured by a security interest, senior to any current and future debts and to any security interest, in all of our rights, title, and interest in, to and under substantially all of our assets, subject to limited exceptions, including permitted liens. Upon termination, these liens and all other obligations under the credit agreement, were released. A letter of credit remains at Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the Federal Deposit Insurance Corporation as Receiver for Silicon Valley Bridge Bank, N.A.) as successor to Silicon Valley Bank, in the amount of $ 5.9 million, securing our lease on our corporate headquarters. This letter of credit was transitioned to a cash collateral arrangment on March 30, 2023, and is classified as long-term restricted cash on our balance sheet at June 30, 2023.
16
Table of Contents
Note 13. Income Taxes
Income tax expense was $ 3.0 million for the three months ended June 30, 2023, compared to $ 4.0 million for the three months ended June 30, 2022. The $ 1.0 million decrease was primarily due to a higher stock compensation deduction driven by an increase in stock price offset partially by an increase in pre-tax financial reporting income. Income tax expense was $ 8.2 million for the six months ended June 30, 2023, compared to $ 8.3 million for the six months ended June 30, 2022.
The effective tax rate for the three and six months ended June 30, 2023 was less than the U.S. statutory rate of 21 % due to a forecasted Foreign Derived Intangible Income deduction, Federal research and development tax credits and a favorable discrete item related to equity compensation that reduces the annual tax rate.
The deferred income taxes of $ 38.9 million and $ 31.7 million as of June 30, 2023 and December 31, 2022, respectively, reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. As of June 30, 2023, we have recorded a $ 10.6 million valuation allowance in the U.S. against certain tax credits and state net operating losses due to the uncertainty of their realization. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be impacted by market conditions and other variables not known or anticipated at this time.
Note 14. Concentration of Risk
For the three months ended June 30, 2023, no individual customer accounted for greater than ten percent of revenue. For the three months ended June 30, 2022, two customers accounted for 19.3 % and 11.6 % of total revenue, respectively.
For the six months ended June 30, 2023, two customers accounted for 11.6 % and 11.1 % of total revenue, respectively. For the six months ended June 30, 2022, three customers accounted for 15.3 %, 10.7 % and 10.3 % of total revenue, respectively.
At June 30, 2023, two customers accounted for 12.5 % and 11.5 % of accounts receivable, respectively. At December 31, 2022, two customers accounted for 19.4 % and 11.5 % of accounts receivable, respectively.
Note 15. Share Repurchase
In February 2022, our Board of Directors approved stock repurchases of up to $ 100 million of our common stock. During the six months ended June 30, 2023, we repurchased 0.2 million shares at an average cost of $ 123.80 per share. The timing and actual number of any additional shares to be repurchased under this program will depend on various factors including price, corporate and regulatory requirements, alternative investment opportunities and other market conditions.
Repurchased shares are accounted for when the transaction is settled and returned to the status of authorized but unissued shares. Accordingly, the repurchases are deducted from common stock for par value and from additional paid-in capital for the excess over par value. If additional paid-in capital has been exhausted, the excess over par value is deducted from retained earnings. Direct costs incurred to acquire the shares are included in the total cost of the shares.
Note 16. Contingencies
(a) Litigation
We are from time to time a party to litigation that arises in the normal course of our business operations. We are not presently a party to any litigation that we believe might have a material adverse effect on our business operations.
(b) Indemnifications
Our system sales agreements typically include provisions under which we agree to take certain actions, provide certain remedies and defend our customers against third-party claims of intellectual property infringement under specified conditions and indemnify customers against any damage and costs awarded in connection with such claims. We have not incurred any material costs as a result of such indemnifications and have not accrued any liabilities related to such obligations in the accompanying consolidated financial statements.
17
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.